Back to Search
Start Over
α1-Antitrypsin deficiency and the risk of COVID-19: an urgent call to action.
- Source :
-
The Lancet. Respiratory medicine [Lancet Respir Med] 2021 Apr; Vol. 9 (4), pp. 337-339. Date of Electronic Publication: 2021 Jan 21. - Publication Year :
- 2021
- Subjects :
- COVID-19 diagnosis
COVID-19 genetics
Clinical Trials as Topic
Comorbidity
Genetic Predisposition to Disease
Humans
Mutation
Risk Factors
SARS-CoV-2 metabolism
Serine Endopeptidases metabolism
Serine Proteinase Inhibitors pharmacology
Serine Proteinase Inhibitors therapeutic use
Severity of Illness Index
Virus Internalization drug effects
alpha 1-Antitrypsin metabolism
alpha 1-Antitrypsin pharmacology
alpha 1-Antitrypsin therapeutic use
alpha 1-Antitrypsin Deficiency genetics
COVID-19 Drug Treatment
COVID-19 epidemiology
alpha 1-Antitrypsin genetics
alpha 1-Antitrypsin Deficiency epidemiology
Subjects
Details
- Language :
- English
- ISSN :
- 2213-2619
- Volume :
- 9
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- The Lancet. Respiratory medicine
- Publication Type :
- Academic Journal
- Accession number :
- 33485406
- Full Text :
- https://doi.org/10.1016/S2213-2600(21)00018-7